Key result
Rapid pacing-induced electrical remodeling in rabbits enhanced the AERP-prolonging effects of ranolazine and tertiapin-Q, in contrast to dl-sotalol, bepridil, amiodarone, and vernakalant.
Why the study?
Do ranolazine, tertiapin-Q, and other antiarrhythmic drugs prolong atrial effective refractory period differently in rabbits with rapid pacing-induced electrical remodeling compared to controls?
Do ranolazine, tertiapin-Q, and other antiarrhythmic drugs prolong atrial effective refractory period differently in rabbits with rapid pacing-induced electrical remodeling compared to controls?
Electrical remodeling induced by rapid pacing in rabbits enhances the AERP-prolonging effects of ranolazine and tertiapin-Q compared to standard antiarrhythmic drugs.
May enhance ranolazine and tertiapin-Q effects in remodeled atria; hypothesis-generating and leaves clinical translation open.
Electrical remodeling plays a pivotal role in maintaining the reentry during atrial fibrillation. In this study, we assessed influence of electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits. We used an atrial electrical remodeling model of the rabbit, subjected to rapid atrial pacing (RAP; 600 beats/min) for 2-4 weeks, leading to shortening of atrial effective refractory period (AERP). Intravenous administration of dl-sotalol (6 mg/kg), bepridil (1 mg/kg), amiodarone (10 mg/kg) or vernakalant (3 mg/kg) significantly prolonged the AERP both in the control and RAP rabbits. The extents in the RAP rabbits were similar to those in the control animals. On the other hand, prolonging effects of intravenously administered ranolazine (10 mg/kg) or tertiapin-Q (0.03 mg/kg) on the AERP in the RAP rabbits were more potent than those in the control animals. These results suggest that rapid pacing-induced electrical remodeling effectively modified the prolonging effects of ranolazine and tertiapin-Q on the AERP in contrast to those of clinically available antiarrhythmic drugs, dl-sotalol, bepridil amiodarone and vernakalant.
No takes yet. Share an insight, caveat, or question.
Chiba et al. (2016) studied Atrial fibrillation (electrical remodeling). Antiarrhythmic drugs (dl-sotalol, bepridil, amiodarone, vernakalant, ranolazine, tertiapin-Q) vs. Control rabbits was evaluated on Atrial effective refractory period (AERP). Rapid pacing-induced electrical remodeling in rabbits enhanced the AERP-prolonging effects of ranolazine and tertiapin-Q, in contrast to dl-sotalol, bepridil, amiodarone, and vernakalant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: